Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of CKD-828 (S-Amlodipine/Telmisartan) in Essential Hypertension
NCT01128322Phase 2Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jul 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Levamlodipine, telmisartan in essential hypertension, sponsored by Chong Kun Dang Holdings. Started Jul 2010; status: completed.
02
Drugs
Levamlodipinetelmisartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01128322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128322.